Pharmacoeconomic studies: Pitfalls and problems

International Journal of Technology Assessment in Health Care

Volumn 12, Issue 1, 1996, Pages 22-30

  De Graeve, Diana ^a   Nonneman, Walter ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

COST BENEFIT ANALYSIS; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG INDUSTRY; DRUG MARKETING; METHODOLOGY; PHARMACOECONOMICS; REVIEW;

EID: 0029935354     PISSN: 02664623     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0266462300009351     Document Type: Review

References (27)

1. Adams, M., McCall, N., & Gray, D. Economic analysis in randomized control trials. Medical Care, 1992, 30, 231-43.
2. Broome, J. QALYs. Journal of Public Economics, 1992, 50, 149-67.
3. Drummond, M. Economic evaluation of pharmaceuticals: Science or marketing? PharmacoEconomics, 1992, 1, 8-13.
4. Drummond, M., Rutter, F., Brenna, A., et al. Economic evaluation of pharmaceuticals: A European perspective. PharmacoEconomics, 1993, 4, 173-86.
5. Drummond, M., & Davies, L. Economic analysis alongside clinical trials: Revisiting the methodological issues. International Journal of Technology Assessment in Health Care, 1991, 7, 561-73.
6. Drummond, M. G., Stoddart, G., & Torrance, G. W. Methods for the economic evaluation of health care programs. Oxford: Oxford Medical Publications, 1987.
7. Gramlich, E. M. A guide to benefit-cost analysis. Englewood Cliffs, NJ: Prentice Hall, 1990.
8. Guyatt, G., Drummond, M., Feeny, D., et al. Guidelines for the clinical and economic evaluation of health care technologies. Social Science and Medicine, 1986, 22, 393-408.
9. Henry, D. Economic analysis as an aid to subsidization: The development of Australian guidelines for pharmaceuticals. PharmacoEconomics, 1992, 54-67.
10. Hillman, A., Eisenberg, J., Pauly, M. et al. Avoiding bias in the conduct of cost-effectiveness research sponsored by pharmaceutical companies. New England Journal of Medicine, 1991, 324, 1362-65.
11. Hutton, J. Economic evaluation of health care: A half-way technology. Health Economics, 1994, 3, 1-4.
12. Jonsson, B. Cost-benefit analysis of hepatitis B vaccination. Postgraduate Medical Journal, 1987, 63(suppl. 2), 27-32.
13. Katz, D. A., & Welch, G. Discounting in cost-effectiveness analysis of health care programs. PharmacoEconomics, 1993, 3, 276-85.
14. Mooney, G., & Olson, J. A. QALYs: Where next? In A. McGuire, P. Fenn, & K. Meyhew (eds.) Providing health care. Oxford: Oxford University Press, 1991, 120-40.
15. Nord, E. Toward quality assurance in QALY calculations. International Journal of Technology Assessment in Health Care, 1993, 9, 37-45.
16. Nord, E., Richardson, J., & Macarounas-Kirchman, K. Social evaluation of health care versus personal evaluation of health states: Evidence on the validity of four health-state scaling instruments using Norwegian and Australian data. International Journal of Technology Assessment in Health Care, 1993, 9, 463-78.
17. OECD. Managing with market-type mechanisms. Paris: Public Management Studies, 1993.
18. Olson, J. A. Persons versus years: Two ways of eliciting implicit weights. Health Economics, 1994, 3, 39-46.
19. Petrou, S., Malek, M., & Davey, P. G. The reliability of cost-utility estimates in cost-per-QALY league tables. PharmacoEconomics, 1993, 3, 345-53.
20. Russell, L. B. Is prevention better than cure? Washington, DC: The Brookings Institution, 1986.
21. Scherer, F. M. Pricing, profits and technological progress in the pharmaceutical industry. Journal of Economic Perspectives, 1993, 7, 97-115.
22. Sheldon, T. A. Discounting in health care decision-making: Time for a change? Journal of Public Health Medicine, 1992, 14, 250-56.
23. Smith, R. D., & Dobson, M. Measuring utility values for QALYs: Two methodological issues. Health Economics, 1993, 2, 349-55.
24. Udvarhelyi, S., Colditz, G., Rai, A., et al. Cost-effectiveness and cost-benefit analysis in the medical literature: Are the methods being used correctly? Annals of Internal Medicine, 1992, 116, 238-44.
25. Weinstein, M. Principles of cost-effective resource allocation in health care organizations. International Journal of Technology Assessment in Health Care, 1990, 6, 93-103.
26. Weinstein, M., & Fineberg, H. V. Clinical decision analysis. New York: W. B. Saunders, 1980.
27. Weisbrod, B. A. The health care quadrilemma: An essay on technological change, insurance, quality of care, and cost containment. Journal of Economic Literature, 1991, 24, 523-52.